First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
07 sept. 2021 08h30 HE
|
University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
Focusing on Solutions to the Opioid Crisis, Foundation for Opioid Response Efforts (FORE) Announces Family- and Community-Based Initiatives to Prevent Substance Use Disorder and Overdose
20 juil. 2021 11h00 HE
|
Foundation for Opioid Response Efforts
New York, July 20, 2021 (GLOBE NEWSWIRE) -- It is estimated that one in eight (8.7 million) children ages 17 or younger in the United States live in a household where at least one parent has had a...
Insights on the Mental Health Disorder Pharmaceutical Treatments Global Market to 2025 - Players Include Eli Lilly, Johnson & Johnson and Pfizer Among Others
26 févr. 2021 05h38 HE
|
Research and Markets
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Treatments for Mental Health Disorders: Global Markets" report has been added to ResearchAndMarkets.com's offering. This new report...
UPMC Center for High-Value Health Care Awarded $1 Million to Support Substance Use Disorder Care in Bedford and Somerset Counties
21 sept. 2020 10h42 HE
|
UPMC Health Plan
PITTSBURGH, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The UPMC Center for High-Value Health Care (Center), a nonprofit research organization housed within UPMC Health Plan, was awarded $1 million from the...
Delaware Grows Partnership with Appriss Health to Integrate Prescription Monitoring Program Into its Electronic Health Record System via PMP Gateway Solution
24 juin 2020 10h00 HE
|
Appriss Health
Louisville, KY and Dover, DE, June 24, 2020 (GLOBE NEWSWIRE) -- LOUISVILLE, KY & DOVER, DE – June 22, 2020 – Appriss Health, provider of the most comprehensive platform for opioid stewardship...
TRHC Praises Signing of SUPPORT for Patients and Communities Act
01 nov. 2018 08h00 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, applauds the signing...
Addiction Policy Forum Launches “How Do You Really Keep Your Kids Safe From Addiction?”
23 oct. 2018 03h01 HE
|
Addiction Policy Forum
Washington, DC, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Addiction Policy Forum, a leading addiction nonprofit, has developed the “How Do You Really Keep Your Kids Safe From Addiction?” toolkit to support...
CareFirst to Invest $1.5 Million to Increase Substance Use Disorder Services
09 avr. 2018 11h06 HE
|
CareFirst BlueCross BlueShield
Baltimore, Md., April 09, 2018 (GLOBE NEWSWIRE) -- CareFirst BlueCross BlueShield (CareFirst), the region’s largest not-for-profit insurer, plans to award $1.5 million over two years to programs...
Appriss Health Partners with ClariCare to Deliver Prescription Drug Monitoring Program Information and Advanced Analytics to Dentists through an Integrated Solution to Aid in Appropriate and Safe Prescribing Practices
14 févr. 2018 15h53 HE
|
Appriss Health
Louisville, KY, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Appriss Health, provider of the most comprehensive platform for substance use disorder (SUD) in the U.S., today announced a successful pilot that...
Appriss Health Partners with Kansas to Integrate K-TRACS Prescription Drug Monitoring Program Data Into Electronic Health Records and Pharmacy Management Systems Statewide
19 sept. 2017 14h00 HE
|
Appriss Health
Louisville, KY, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Appriss Health, provider of the most comprehensive platform for substance use disorder in the U.S., today announced that it has entered into an...